✦ LIBER ✦

Does reductive metabolism predict response to tirapazamine (SR 4233) in human non-small-cell lung cancer cell lines?

✍ Scribed by Chinje, E C; Patterson, A V; Saunders, M P; Lockyer, S D; Harris, A L; Stratford, I J

Book ID: 110002599
Publisher: Nature Publishing Group
Year: 1999
Tongue: English
Weight: 98 KB
Volume: 81
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6690819

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Xenobiotic-metabolizing enzyme activity

Xenobiotic-metabolizing enzyme activity in human non-small-cell derived lung cancer cell lines

✍ Miriam Falzon; James B. McMahin; Hildegard M. Schuller 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 752 KB

Can chemosensitivity testing predict res

Can chemosensitivity testing predict response to chemotherapy regimens in non-small cell lung cancer?

✍ Kawamura, M; Abiko, T; Gika, M; Kobayashi, K 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 106 KB

Predicting response to paclitaxel/carbop

Predicting response to paclitaxel/carboplatin-based therapy in non-small cell lung cancer

✍ Rafael Rosell; Enriqueta Felip 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 946 KB

Tumor-infiltrating lymphocytes predict r

Tumor-infiltrating lymphocytes predict response to chemotherapy in patients with advance non-small cell lung cancer

✍ Hui Liu, Tiantuo Zhang, Jin Ye, Hongtao Li, Jing Huang, Xiaodong Li, Benquan Wu, 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 392 KB

Resistance to cisplatin renders high met

Resistance to cisplatin renders high metastatic potential in human non-small cell lung cancer cell line

✍ Kim, J; Soo Yoon, S; Sung Ahn, K; Hyung Choi, J; Lee, Hyun Ik 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 106 KB

In vitro response of human small-cell lu

In vitro response of human small-cell lung-cancer cell lines to chemotherapeutic drugs; no correlation with clinical data

✍ E. F. Smit; E. G. E. de Vries; H. Timmer-Bosscha; L. F. H. M. de Leij; J. W. Oos 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 French ⚖ 844 KB

Three cell lines derived from small-cell lung carcinoma (SCLC) tumors of patients who had no clinical response after treatment with a multi-drug regimen were compared to 3 cell lines derived from tumors of patients who, upon treatment, showed a complete clinical response. These 2 groups of cell line